选择语言

Human PD-1 (Luc) Jurkat Reporter Cell

用户评价
货号-规格
价格
Qty.
SCJUR-STF064-2Vials (1Vial X 2)
询价
合计0件 产品金额¥ 0

产品详情

    1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
    2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
    3. Comprehensive application data to support assay development and validation
    4. Full tracible record, stringent quality control and validated cell passage stability
    5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
    6. Global commercial license assistance whenever regulatory filing is required
  • 描述(Description)

    The Human PD-1 (Luc) Jurkat Reporter Cell was engineered to not only express the NFAT response element driving luciferase expressing systems, but also express the receptor full length human PD-1 (Gene ID: 5133), which can use to evaluate the potency of PD-1 blockade. When cocultured with target cells expressing human PD-L1, the PD-1/PD-L1 interaction inhibits TCR signaling and NFAT-mediated luminescence. Blocking the PD-1/PD-L1 interaction by either anti-PD-1 or anti-PD-L1 antibodies releases the inhibitory signal and results in TCR activation and NFAT-mediated luminescence.

  • 应用说明(Application)

    • Screen for anti-human PD-1 or anti-human PD-L1 antibody.

    PD-1 Assay Principles

  • 生长特性(Growth Properties)

    Suspension

  • 筛选标记(Selection Marker)

    Puromycin (5 μg/mL) + Hygromycin (20 μg/mL)

  • 培养基(Complete Growth Medium)

    RPMI-1640 + 10% FBS

  • 冻存液(Freeze Medium)

    Serum-free cell cryopreservation medium

  • 装量(Quantity)

    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

  • 存储(Storage)

    Frozen in liquid nitrogen.

  • 支原体检测(Mycoplasma Testing)

    Negative

  • 无菌检测(Sterility Testing)

    Negative

  • 使用说明(Instructions for Use)

    See data sheet for detailed culturing and assay protocol.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

数据展示

  • Receptor Assay

     PD-1 FACS

    Expression analysis of human PD-1 on Human PD-1 (Luc) Jurkat Reporter Cell by FACS.
    Cell surface staining was performed on Human PD-1 (Luc) Jurkat Reporter Cell or negative control cell using FITC-labeled anti-human PD-1 antibody.

    Protocol
  • Application

     PD-1 APPLICATION

    Blocking activity of anti-human PD-1 antibody (RLU).
    This reporter cell was incubated with serial dilutions of Anti-human PD-1 Antibody in the presence of target cells expressing human PD-L1. The EC50 was approximately 1.189 μg/mL.

    Protocol
  •  PD-1 APPLICATION

    Blocking activity of anti-human PD-1 antibody (FOLD).
    This reporter cell was incubated with serial dilutions of Anti-human PD-1 Antibody in the presence of target cells expressing human PD-L1. The max induction fold was approximately 22.47.

    Protocol
  • Passage Stability

     PD-1 PASSAGE

    Passage stability analysis by Signaling Bioassay.
    The continuously growing Human PD-1 (Luc) Jurkat Reporter Cell was stimulated with serial dilutions of Anti-human PD-1 antibody in the presence of target cells expressing human PD-L1. Anti-human PD-1 antibody stimulated response demonstrates passage stabilization (fold induction and EC50) across passage 12-36.

    Protocol
*如有相关细胞池需求请联系我们

用户评价
发表评论

背景介绍

Programmed cell death protein 1 (PD-1) is also known as CD279 and PDCD1, is a type I membrane protein and is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 is expressed on the surface of activated T cells, B cells, macrophages, myeloid cells and a subset of thymocytes. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-γ by suppressing the activation and transduction of PI3K/AKT pathway.

重要声明

  • Limited Use&License Disclosure

    BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE FOLLOWING TERMS OF LIMITED USE OF THIS CELL LINE PRODUCT.

    1. If the researcher is not willing to accept the terms of limited use of this cell line product, and the product is unused, ACRO will accept return of the unused product.
    2. Researchers may use this product for research use only, no commercial use is allowed. "Commercial use" means any and all uses of this product and derivatives by a party for profit or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research.
    3. This cell line is neither intended for any animal or human therapeutic purposes nor for any direct human in vivo use. You have no right to share, modify, transfer, distribute, sell, sublicense, or otherwise make the cell line available for use to other researchers, laboratories, research institutions, hospitals, universities, or service organizations.
    4. ACROBIOSYSTEMS MAKES NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, EITHER EXPRESSED OR IMPLIED, WITH RESPECT TO THE SUITABILITY OF THE CELL LINE FOR ANY PARTICULAR USE.
    5. ACROBIOSYSTEMS ACCEPTS NO LIABILITY IN CONNECTION WITH THE HANDLING OR USE OF THE CELL LINE.
    6. Modifications of the cell line, transfer to a third party, or commercial use of the cell line may require a separate license and additional fees. Please contact order.cn@acrobiosystems.com for further details.

前沿进展

 
药物研发进展
  • 英文全称:

    Programmed cell death protein 1

  • 中文全称:

    细胞程序性死亡-1

  • 种类:

  • 上市药物数量:

    20 详情

  • 临床药物数量:

    167 详情

  • 最高研发阶段:

    临床三期

联系我们
项目合作
查看更多项目
  • 产品基础信息
  • 产品详情
  • 数据展示
  • 用户评价
  • 背景介绍
  • 重要声明